Clinical Trial Update: Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates combining fresh frozen plasma with Rituximab (Mabthera) in patients with advanced refractory chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Wolfson Medical Center | Conditions: Advanced Refractory Chronic Lymphocytic Leukemia | Phase 2 | Status: UNKNOWN